The EPS for the most recent quarter is 1.68. Finally, Gibraltar Capital Management Inc. increased its stake in Express Scripts Holding by 2.3% in the third quarter. BloombergSen Inc. now owns 1,396,497 shares of the company's stock worth $105,854,000 after buying an additional 71,949 shares in the last quarter. Finally, PGGM Investments purchased a new stake in Express Scripts Holding during the second quarter worth approximately $35,563,000. Northwestern Mutual Wealth Management Co. now owns 185,443 shares of the company's stock worth $14,057,000 after buying an additional 12,057 shares during the last quarter. Its share price has grown 4.37% in three months and is down -0.07% for the last five trades. The correct version of this article can be read at https://www.thecerbatgem.com/2016/11/30/daiwa-securities-group-inc-has-3537000-stake-in-express-scripts-holding-co-esrx.html. Return on Equity (ROE) stands at 17.4% and Return on Investment (ROI) displays a value of 9%. (NASDAQ:ESRX) traded down 1.28% on Wednesday, reaching $75.88.
A number of equities analysts recently commented on the company. The stock's market capitalization is 46.79B, it has a 52-week low of 64.46 and a 52-week high of 89.00.
The 20-day Simple Moving average for Express Scripts Holding Company NASDAQ is measured to be 5.88% in conjunction with the 200-Day Simple Moving Average of 3.93%. Analysts had expected Express Scripts Holding Company (NASDAQ:ESRX) to post net income of about $1.74 per share on $25,494.30M in revenue. The stock next year first quarter current estimate trend for EPS was for $-0.20 and on annual basis FY 2016 estimate trends at current was for $-0.71 as compared to one month ago of $-0.74, and for next year per share earnings estimates have $-0.66. The firm earned $25.41 billion during the quarter, compared to the consensus estimate of $25.48 billion.
02/18/2016 - Express Scripts Holding Company had its "neutral" rating reiterated by analysts at Goldman Sachs. The company's quarterly revenue was up.7% compared to the same quarter past year. 1 Month Ago, shares have been suggested as BUY from 4 and 0 issued SELL signal for the company's stock. In the last 27 earnings reports, the company has topped earnings-per-share estimates 41% percent of times.
TRADEMARK VIOLATION WARNING: "TIAA CREF Trust Co".
Shares of Express Scripts Holding Co. "(ESRX)" was posted by Community Financial News and is owned by of Community Financial News. If you are reading this report on another site, it was copied illegally and reposted in violation of USA and global copyright & trademark legislation.
Indicating how profitable Express Scripts Holding Company NASDAQ is relative to its assets, the ROA value is displayed at 5.30%. In the past 52 weeks, the share price moved between $60.05 and $74.97.
Express Scripts Holding Company (NASDAQ:ESRX) stock is presently standing at about $76.86 and lots of equity research firms seem to have a target price set on the stock.
When the current quarter ends, Wall Street expects Express Scripts Holding Company to have earnings per share of $1.87. Leerink Swann reiterated a "market perform" rating and issued a $80.00 target price on shares of Express Scripts Holding in a research note on Thursday, September 1st. Sumitomo Mitsui Trust Holdings Inc. now owns 2,177,155 shares of the company's stock worth $165,028,000 after buying an additional 8,030 shares during the last quarter. The company has an average rating of "Hold" and an average target price of $80.78. Also, VP Christopher A. Mcginnis sold 1,785 shares of the company's stock in a transaction that occurred on Monday, September 12th. The share price of ELGX attracts active investors, as stock price of week volatility recorded 4.67%. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The stock was sold at an average price of $70.77, for a total value of $126,324.45. Following the transaction, the director now directly owns 14,918 shares of the company's stock, valued at approximately $1,050,227.20. The disclosure for this sale can be found here. The price to earnings ratio for the company is 19.22 with a beta of 0.11.